Ubique
1 known investors
Ubique Biotech develops AI-designed synthetic reagents (antigen and antibody based) for precision diagnostics used in formats such as ELISA and rapid point-of-care tests. Founded in 2022, it focuses on affordable, scalable disease detection and screening without extensive laboratory infrastructure.
Investors · 1
Frequently asked questions
- What does Ubique do?
- Ubique Biotech develops AI-designed synthetic reagents (antigen and antibody based) for precision diagnostics used in formats such as ELISA and rapid point-of-care tests. Founded in 2022, it focuses on affordable, scalable disease detection and screening without extensive laboratory infrastructure.
- Who are Ubique's investors?
- Ubique's investors include GRIDX.